Cellectar Biosciences, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€0.00 - Gross profit
€0.00 - SG&A expenses
€18.01M - R&D expenses
€15.03M - EBITDA
-€32.88M - D&A
€165.34K - EBIT
-€33.04M - Interest expenses
€0.00 - EBT
-€24.89M - Tax expenses
€56.63K - Net income
-€24.94M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€7.29M - Changes in working capital
-€1.20M - Operating cash flow
-€29.67M - Capex
€52.58K - Other investing cash flow
€0.00 - Net investing cash flow
-€52.58K - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€17.00M - Net financing cash flow
€17.00M - Foreign exchange effects
€0.00 - Net change in cash
-€12.72M - Cash at end of period
€9.47M - Free cash flow
-€29.62M
Balance sheet
- Cash and cash equivalents
€9.47M - Cash and short-term investments
€9.47M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€1.35M - Total current assets
€10.83M - Property, plant & equipment
€899.01K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€25.55K - Total non-current assets
€924.56K - Total assets
€11.75M - Accounts payable
€4.01M - Short-term debt
€78.95K - Other current liabilities
€940.31K - Total current liabilities
€5.03M - Long-term debt
€310.16K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€310.16K - Total liabilities
€5.34M - Common stock
€15.44 - Retained earnings
-€222.56M - Other equity
€0.00 - Total equity
€6.41M - Total liabilities and shareholders' equity
€11.75M
Company information
- Market capitalization
€310.50M - Employees
11 - Enterprise Value
€6.24M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-389.3% Much better than peer group: -439.9% - ROA
-
-212.3% Much better than peer group: -1,144.5% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-9.6% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€2.27M